Kura Oncology will announce their financial results for the second quarter of 2024.

SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the…

Read More: https://www.globenewswire.com/news-release/2024/08/01/2922665/35186/en/Kura-Oncology-to-Report-Second-Quarter-2024-Financial-Results.html